New Research: Is Telomere Shortening a Key Biomarker for Sjögren's Disease?

A recent study explored a fascinating link between Sjögren's Disease (SjD) and the protective "caps" on our DNA, suggesting a potential new way to diagnose and assess risk for the condition.

What is a Telomere?

To understand this research, think of your DNA chromosomes as shoelaces. Telomeres are the plastic tips on the ends of those laces. They protect the main DNA from damage as your cells divide. Over time and with age, these telomeres naturally get shorter

The Study's Focus

Researchers wanted to see if there was a difference in telomere length between people with Sjögren's Disease and healthy individuals. They focused on leukocytes, which are your white blood cells—the key players in your immune system.

What the Researchers Found

The study analyzed 181 participants (87 people with Sjögren's Disease and 94 healthy controls) and found two major results:

1. Shorter Telomeres in SjD: On average, people with Sjögren's Disease had significantly shorter telomeres in their white blood cells compared to the healthy group.

2. Increased Risk: A reduced telomere length was strongly linked to a higher likelihood of a person having Sjögren's Disease. The data suggested that the more the telomeres shortened, the higher the probability of developing the condition.

What This Means for Sjögren's Disease

This cross-sectional study suggests that a reduction in telomere length in white blood cells could serve as a promising biomarker for Sjögren's Disease.

In simple terms, checking telomere length could potentially be used for:

• Early Detection: Helping to identify the disease earlier.

• Risk Assessment: Giving doctors a new tool to assess the severity or risk of developing SjD.

The findings imply that this progressive shortening of telomeres might not just be a side effect, but potentially contribute to the immune dysregulation and chronic inflammation that defines Sjögren's Disease.

Next Steps

While this is an important finding, the researchers stress that more work is needed. Future studies are necessary to confirm if telomere shortening actually causes Sjögren's Disease or if it's simply a result of the disease process. This will help determine if future treatments could potentially focus on protecting or lengthening telomeres.

---

Source: A cross-sectional study on Telomere length in leukocyte as biomarker for diagnosis of primary Sjögren’s syndrome. Published in Clinical Rheumatology, November 2025.